Mindray Medical: Completed the cancellation of 642,000 shares of treasury stock, resulting in a decrease in total registered capital.

Mindray Medical announced that, due to the failure to meet the performance assessment targets at the company level for the third batch of shares unlocking under the 2022 employee stock ownership plan, the company plans to cancel the remaining 641,963 shares from this plan. As of August 7, 2026, the cancellation procedures have been completed at the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited, reducing the total share capital of the company from 1,212,441,394 shares to 1,211,799,431 shares. This cancellation will not have a substantial impact on the company's operating performance or financial condition.